AIM
AIM ImmunoTech
35 hedge funds and large institutions have $1.67M invested in AIM ImmunoTech in 2022 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
Holders
35
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$21.9K | |
| 2 | +$7.19K | |
| 3 | +$4.5K | |
| 4 |
Renaissance Technologies
New York
|
+$3.77K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.56K |
Top Sellers
| 1 | -$150K | |
| 2 | -$12K | |
| 3 | -$9K | |
| 4 |
Millennium Management
New York
|
-$3.69K |
| 5 |
VF
Virtu Financial
New York
|
-$2.46K |